Forte Biosciences, Inc. (37T)
XSTU
65.50
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
65.5065.50
52 wk Range
8.7068.50
Financial Statements - 37T - Forte Biosciences, Inc.
Revenue
0
Net Income
-69.37M▼ 95.5%
EBITDA
-70.59M▼ 93.1%
Free Cash Flow
-50.99M▼ 65.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 0 | 0 |
| Cost of Goods | - | - |
| Gross Profit | - | - |
 Operating Expense | - | - |
| Operating Income | -70.65M | -36.60M |
| Non-Operating Interest | - | - |
| Other Income Expense | -396K | -190K |
| Pre Tax Income | -68.33M | -35.47M |
| Income Tax | 1.03M | - |
| Net Income | -69.37M | -35.47M |
| EPS Basic | -4.71 | -12.17 |
| EPS Diluted | -4.71 | -12.17 |
| Basic Shares Outstanding | 14.71M | 2.91M |
| Diluted Shares Outstanding | 14.71M | 2.91M |
| Ebit | -70.65M | -36.60M |
| Ebitda | -70.59M | -36.56M |
| Net Income Continuous Operations | -69.37M | -35.47M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
